- Alternative Medicine
- Mesothelioma Cure
- Mesothelioma Research
- Mesothelioma Doctors
- Mesothelioma Cancer Centers
- Mesothelioma Clinical Trials
Over 30 Billion dollars in trust fund money has been set aside for asbestos victims.
Get a Free copy of Surviving Mesothelioma, Lean on Me, or 100 Questions & Answers About Mesothelioma
Mesolink.org now offeres Free Assistance with VA Claims and other benefits.
Joan H Schiller, M.D.
Contact Information
- 5323 Harry Hines Boulevard, Dallas, Texas 75390
- (214) 645-8300
- joan.schiller@utsouthwestern.edu
Known as a pre-eminent researcher and clinician in the area of lung cancer, Joan H. Schiller, M.D. is currently Chief of the Hematology/Oncology Division of the Department of Internal Medicine and a Professor at the University of Texas Southwestern Medical Center.
In affiliation with the Harold C. Simmons Comprehensive Cancer Center, where Schiller is the Deputy Director, she also serves as the Andrea L. Simmons Distinguished Chair in Cancer Research. She is board-certified in internal medicine and also is a diplomat of the Medical Oncology Board. Before moving to Texas, Dr. Schiller served as Professor of Medicine in the Department of Medicine Section of Oncology at the University of Wisconsin in Madison.
The research in the Hematology/Oncology division is, for the most part, performed at the Hamon Center for Therapeutic Oncology Research. Historically, chief areas of inquiry center on laboratory models of chronic myelogenous leukemia, sarcoma genetics, and the protein cellular signaling in the context of cancer. The fellows and active staff in the Division of Hematology Oncology are always recruiting patients into ongoing clinical trials.
Dr. Schiller carried out her undergraduate medical training at the University of Illinois at Chicago, receiving her M.D. degree in 1980. She then completed a residency in internal medicine at Northwestern Memorial Hospital, from 1981 to 1983. She spent the following year conducting research as a resident at the University of Wisconsin Clinical Cancer Center. She then finished a fellowship in oncology at the same facility, with a subsequent appointment to the faculty there. She moved to UT-Southwestern in 2006.
Dr. Schiller is widely considered an authority in her field, and she has received a variety of awards. In 2006 and 2007, she was chosen as one of America’s Top Doctors in Cancer. She also received recognition as an America’s Top Doctor in 2007 and 2008. She has also been awarded the Lynn Kotsiantos Lifetime Achievement Award by the Respiratory Health Association of Chicago for her work in raising awareness of issues surrounding lung cancer. Dr. Schiller is a sitting Co-Chairman of the Scientific Leadership Council in Lung Cancer. She also serves as Chairman of the Thoracic Oncology Committee of the Eastern Cooperative Oncology Group. Schiller founded the National Lung Cancer Partnership, currently functioning as President. Professionally, she is affiliated with the Eastern Co-Operative Oncology Group, the American Society of Clinical Oncology, and the International Association for the Study of Lung Cancer.
Dr. Schiller’s research targets lung cancer, specifically new therapeutic modalities for small-cell and non-small-cell lung cancer. She participates in multiple clinical trials in all phases of investigation, and she actively cares for patients with lung cancer in her clinic, assisted by her colleagues in thoracic surgery and radiation therapy. Internationally acclaimed for her work with lung cancer, she has published several peer-reviewed articles pertaining to the diagnosis and treatment of this disease. An interesting avenue of her research involves the use of an implanted device that studies tumor cells circulating in the blood stream. This medical device, if trials are successful, will revolutionize the method doctors use to assess the efficacy of treatment for a variety of cancers, including mesothelioma.